Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours
- 2 July 2010
- journal article
- research article
- Published by Informa UK Limited in International Journal of Hyperthermia
- Vol. 26 (5), 485-498
- https://doi.org/10.3109/02656731003789284
Abstract
Purpose: In previous reports, laboratory-made lysolecithin-containing thermosensitive liposome encapsulating doxorubicin (LTSL-DOX) showed potent anticancer effects in FaDu human squamous cell carcinoma. To further study the spectrum of LTSL-DOX activity, the efficacy of its commercial formulation was re-examined in FaDu and compared in HCT116, PC3, SKOV-3 and 4T07 cancer cell lines. Factors that may influence differences in HT-LTSL-DOX efficacy were also examined. Methods: Anticancer effect was measured using standard growth delay methods. We measured doubling time and clonogenic survival after doxorubicin exposure in vitro, and interstitial pH and drug concentrations in vivo. Results: In all five tumour types, HT-LTSL-DOX increased median tumour growth time compared with untreated controls (p < 0.0006) and HT alone (p < 0.01), and compared with LTSL-DOX alone in FaDu, PC-3 and HCT-116 (p < 0.0006). HT-LTSL-DOX yielded significantly higher drug concentrations than LTSL-DOX (p < 0.0001). FaDu was most sensitive (p < 0.0014) to doxorubicin (IC50 = 90 nM) in vitro, compared to the other cell lines (IC50 = 129–168 nM). Of the parameters tested for correlation with efficacy, only the correlation of in vitro doubling time and in vivo median growth time was significant (Pearson r = 0.98, p = 0.0035). Slower-growing SKOV-3 and PC-3 had the greatest numbers of complete regressions and longest tumour growth delays, which are clinically important parameters. Conclusions: These results strongly suggest that variations in anti-tumour effect of HT-LTSL-DOX are primarily related to in vitro doubling time. In the clinic, the rate of tumour progression must be considered in design of treatment regimens involving HT-LTSL-DOX.Keywords
This publication has 57 references indexed in Scilit:
- Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposomeInternational Journal of Hyperthermia, 2008
- In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinomaInternational Journal of Hyperthermia, 2006
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Review Hyperthermia and liposomesInternational Journal of Hyperthermia, 1999
- Cellular resistance to anthracyclinesGeneral Pharmacology: The Vascular System, 1996
- Potentiation of dna‐adduct formation and cytotoxicity of platinum‐containing drugs by low pHInternational Journal of Cancer, 1993
- Manipulation of intra- and extracellular pH in spontaneous canine tumours by use of hyperglycaemiaInternational Journal of Hyperthermia, 1993
- Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasisInternational Journal of Cancer, 1991
- Human tumour pH and its variationEuropean Journal of Cancer and Clinical Oncology, 1985